| Q94141568 | A Case of Congenital Complete Atrioventricular Block Treated with Transdermal Tulobuterol |
| Q37950622 | Anti-Ro antibodies and neonatal lupus |
| Q40490976 | Antibody Mediated Complete Congenital Heart Block in the Fetus |
| Q89128312 | At the heart of programming: the role of micro-RNAs |
| Q35216319 | Autoantibody-associated congenital heart block: the clinical perspective |
| Q33356675 | Autoimmune disease in pregnancy |
| Q69493179 | Autoimmune disease in pregnancy |
| Q41519678 | Autoimmune disease in pregnancy. Systemic lupus erythematosus and antiphospholipid syndrome. |
| Q46358042 | Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry |
| Q41122374 | Cardiac abnormalities associated with hydrops fetalis |
| Q37245872 | Collagen vascular diseases of childhood |
| Q72879594 | Complete congenital heart block in autoimmune hepatitis (SLA-positive) |
| Q38761005 | Congenital AV-block: role of anti-Ro and anti-La antibodies |
| Q34760163 | Congenital heart block in neonatal lupus: the pediatric cardiologist's perspective |
| Q41475197 | Emergency and critical care issues in pediatric rheumatology |
| Q74693232 | Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block |
| Q67470045 | Fetal Echocardiography in the Assessment of Lupus Pregnancies |
| Q82216433 | Identification and management of fetuses at risk for, or affected by, congenital heart block associated with autoantibodies to SSA (Ro), SSB (La), or an HsEg5-like autoantigen |
| Q35119704 | Lupus erythematosus and allied disorders in pregnancy. |
| Q40506568 | Lupus pregnancies and neonatal lupus |
| Q77091376 | Management of collagen vascular diseases in childhood |
| Q41404947 | Management of fetal cardiac arrhythmias |
| Q33402503 | Maternal autoantibodies and pregnancy--II: The neonatal lupus syndrome |
| Q73674771 | Neonatal lupus erythematosus |
| Q71510549 | Neonatal lupus erythematosus with congenital heart block and severe heart failure due to myocarditis and endocardititis of the mitral valve |
| Q44248628 | Neonatal lupus syndrome: review of the literature |
| Q73069257 | Neonatal lupus syndromes |
| Q47616613 | Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution's experience of 30 years |
| Q39756301 | Passively acquired autoimmunity and the maternal fetal dyad in systemic lupus erythematosus |
| Q41775977 | Perinatal outcome of fetal complete atrioventricular block: a multicenter experience |
| Q33562891 | Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus |
| Q27026699 | Prevention and treatment in utero of autoimmune-associated congenital heart block |
| Q70172084 | Rheumatology |
| Q38028943 | Systemic lupus erythematosus and the maternal-fetal dyad |
| Q43790634 | The impact of treatment of the fetus by maternal therapy on the fetal and postnatal outcomes for fetuses diagnosed with isolated complete atrioventricular block. |
| Q72591824 | [Development of an immunoenzyme assay technique of ELISA type for detecting anti-SSB antibodies. Comparative study of 2 kits] |
| Q83020934 | [Obstetrical management of patients at risk of neonatal lupus syndrome: review of the literature] |